BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kaufer AM, Theis T, Lau KA, Gray JL, Rawlinson WD. Laboratory biosafety measures involving SARS-CoV-2 and the classification as a Risk Group 3 biological agent. Pathology 2020;52:790-5. [PMID: 33070960 DOI: 10.1016/j.pathol.2020.09.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Charlton C, Kanji J, Tran V, Kus J, Gubbay J, Osiowy C, Robinson J, Sekirov I, Drebot M, Hatchette T, Stein D, El-Gabalawy N, Lang A, Jiao L, Levett P, Wood H, Therrien C, Lindsay LR, Morshed M, Forbes J, Dibernardo A. Practical guidance for clinical laboratories for SARS-CoV-2 serology testing. Can Commun Dis Rep 2021;47:171-83. [PMID: 34035663 DOI: 10.14745/ccdr.v47i04a01] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yeh KB, Setser B. Aerosol Test Chambers: Current State and Practice During the COVID-19 Pandemic. Front Bioeng Biotechnol 2022;10:863954. [DOI: 10.3389/fbioe.2022.863954] [Reference Citation Analysis]
3 Grau-Expósito J, Perea D, Suppi M, Massana N, Vergara A, Soler MJ, Trinite B, Blanco J, García-Pérez J, Alcamí J, Serrano-Mollar A, Rosado J, Falcó V, Genescà M, Buzon MJ. Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells. PLoS Pathog 2022;18:e1010171. [PMID: 35025963 DOI: 10.1371/journal.ppat.1010171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
4 Vacharathit V, Srichatrapimuk S, Manopwisedjaroen S, Kirdlarp S, Srisaowakarn C, Setthaudom C, Inrueangsri N, Pisitkun P, Kunakorn M, Hongeng S, Sungkanuparph S, Thitithanyanont A. SARS-CoV-2 neutralizing antibodies decline over one year and patients with severe COVID-19 pneumonia display a unique cytokine profile. Int J Infect Dis 2021;112:227-34. [PMID: 34536610 DOI: 10.1016/j.ijid.2021.09.021] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Shuipys T, Montazeri N. Optimized Protocols for the Propagation and Quantification of Infectious Murine Hepatitis Virus (MHV-A59) Using NCTC Clone 1469 and 929 Cells. MPs 2022;5:5. [DOI: 10.3390/mps5010005] [Reference Citation Analysis]
6 Pawar SD, Khare AB, Keng SS, Kode SS, Tare DS, Singh DK, More RL, Mullick J. Selection and application of biological safety cabinets in diagnostic and research laboratories with special emphasis on COVID-19. Rev Sci Instrum 2021;92:081401. [PMID: 34470433 DOI: 10.1063/5.0047716] [Reference Citation Analysis]
7 Heilmann E, Costacurta F, Geley S, Mogadashi SA, Volland A, Rupp B, Harris RS, von Laer D. A VSV-based assay quantifies coronavirus Mpro/3CLpro/Nsp5 main protease activity and chemical inhibition. Commun Biol 2022;5:391. [PMID: 35478219 DOI: 10.1038/s42003-022-03277-0] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Barrera-Avalos C, Luraschi R, Vallejos-Vidal E, Figueroa M, Arenillas E, Barría D, Hernández F, Mateluna C, Mena J, Rioseco C, Torrent C, Vergara C, Gutiérrez G, Quiroz J, Alarcón J, Cartagena J, Cayunao J, Mella-Torres A, Santibañez Á, Tapia S, Undurraga A, Vargas D, Wong V, Inostroza-Molina A, Valdés D, Imarai M, Acuña-Castillo C, Reyes-López FE, Sandino AM. Analysis by real-time PCR of five transport and conservation mediums of nasopharyngeal swab samples to COVID-19 diagnosis in Santiago of Chile. J Med Virol 2021. [PMID: 34755352 DOI: 10.1002/jmv.27446] [Reference Citation Analysis]
9 Rantam FA, Prakoeswa CRS, Tinduh D, Nugraha J, Susilowati H, Wijaya AY, Puspaningsih NNT, Puspitasari D, Husada D, Kurniati ND, Aryati A. Characterization of SARS-CoV-2 East Java isolate, Indonesia. F1000Res 2021;10:480. [PMID: 34621509 DOI: 10.12688/f1000research.53137.1] [Reference Citation Analysis]
10 Loibner M, Barach P, Wolfgruber S, Langner C, Stangl V, Rieger J, Föderl-höbenreich E, Hardt M, Kicker E, Groiss S, Zacharias M, Wurm P, Gorkiewicz G, Regitnig P, Zatloukal K. Resilience and Protection of Health Care and Research Laboratory Workers During the SARS-CoV-2 Pandemic: Analysis and Case Study From an Austrian High Security Laboratory. Front Psychol 2022;13:901244. [DOI: 10.3389/fpsyg.2022.901244] [Reference Citation Analysis]
11 Bagrov DV, Glukhov GS, Moiseenko AV, Karlova MG, Litvinov DS, Zaitsev PА, Kozlovskaya LI, Shishova AA, Kovpak AA, Ivin YY, Piniaeva AN, Oksanich AS, Volok VP, Osolodkin DI, Ishmukhametov AA, Egorov AM, Shaitan KV, Kirpichnikov MP, Sokolova OS. Structural characterization of β-propiolactone inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) particles. Microsc Res Tech 2021. [PMID: 34498784 DOI: 10.1002/jemt.23931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Silva LDC, Dos Santos CA, Mendes GM, Oliveira KG, de Souza Júnior MN, Estrela PFN, Costa SHN, Silveira-Lacerda EP, Duarte GRM. Can a field molecular diagnosis be accurate? A performance evaluation of colorimetric RT-LAMP for the detection of SARS-CoV-2 in a hospital setting. Anal Methods 2021;13:2898-907. [PMID: 34109949 DOI: 10.1039/d1ay00481f] [Reference Citation Analysis]
13 Li H, Xu F, Liu C, Cai A, Dain JA, Li D, Seeram NP, Cho BP, Ma H. Inhibitory Effects and Surface Plasmon Resonance-Based Binding Affinities of Dietary Hydrolyzable Tannins and Their Gut Microbial Metabolites on SARS-CoV-2 Main Protease. J Agric Food Chem 2021;69:12197-208. [PMID: 34586788 DOI: 10.1021/acs.jafc.1c03521] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ieni A, Tuccari G. The COVID-19 pandemic: Pathologists support the clinical infectious diseases team. Int J Infect Dis 2021;104:479-81. [PMID: 33383219 DOI: 10.1016/j.ijid.2020.12.069] [Reference Citation Analysis]
15 Gardner A, Ghosh S, Dunowska M, Brightwell G. Virucidal Efficacy of Blue LED and Far-UVC Light Disinfection against Feline Infectious Peritonitis Virus as a Model for SARS-CoV-2. Viruses 2021;13:1436. [PMID: 34452302 DOI: 10.3390/v13081436] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Das S, Roy A, Das R. New autopsy technique in COVID-19 positive dead bodies: opening the thoracic cavity with an outlook to reduce aerosol spread. J Clin Pathol 2022:jclinpath-2022-208173. [PMID: 35701143 DOI: 10.1136/jclinpath-2022-208173] [Reference Citation Analysis]
17 Le AB, Brown CK, Gibbs SG, Uhrig A, Green AD, Broch Brantsaeter A, Herstein JJ, Vasa A, Shugart J, Wilson Egbe W, Lowe JJ. Best practices of highly infectious decedent management: Consensus recommendations from an international expert workshop. J Occup Environ Hyg 2022;:1-19. [PMID: 35025726 DOI: 10.1080/15459624.2022.2027427] [Reference Citation Analysis]
18 Uengwetwanit T, Chutiwitoonchai N, Wichapong K, Karoonuthaisiri N. Identification of novel SARS-CoV-2 RNA dependent RNA polymerase (RdRp) inhibitors: From in silico screening to experimentally validated inhibitory activity. Computational and Structural Biotechnology Journal 2022. [DOI: 10.1016/j.csbj.2022.02.001] [Reference Citation Analysis]
19 Pedler RL, Speck PG. Marine mollusc extracts-Potential source of SARS-CoV-2 antivirals. Rev Med Virol 2021;:e2310. [PMID: 34726308 DOI: 10.1002/rmv.2310] [Reference Citation Analysis]
20 Yeh KB, Tabynov K, Parekh FK, Mombo I, Parker K, Tabynov K, Bradrick SS, Tseng AS, Yang JR, Gardiner L, Olinger G, Setser B. Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs. Front Bioeng Biotechnol 2021;9:720315. [PMID: 34485259 DOI: 10.3389/fbioe.2021.720315] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Septisetyani EP, Prasetyaningrum PW, Anam K, Santoso A. SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD. Immune Netw 2021;21:e39. [PMID: 35036026 DOI: 10.4110/in.2021.21.e39] [Reference Citation Analysis]
22 Angel DM, Gao D, Delay K, Lin EZ, Eldred J, Arnold W, Santiago R, Redlich C, Martinello RA, Sherman JD, Peccia J, Godri Pollitt KJ. Development and Application of a Polydimethylsiloxane-Based Passive Air Sampler to Assess Personal Exposure to SARS-CoV-2. Environ Sci Technol Lett . [DOI: 10.1021/acs.estlett.1c00877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
23 del Álamo C, Vázquez-calvo Á, Alcamí A, Sánchez-garcía-casarrubios J, Pérez-díaz JL. Assessment of Surface Disinfection Effectiveness of Decontamination System COUNTERFOG® SDR-F05A+ Against Bacteriophage ɸ29. Food Environ Virol. [DOI: 10.1007/s12560-022-09526-z] [Reference Citation Analysis]
24 Salazar-garcía M, Acosta-contreras S, Rodríguez-martínez G, Cruz-rangel A, Flores-alanis A, Patiño-lópez G, Luna-pineda VM. Pseudotyped Vesicular Stomatitis Virus-Severe Acute Respiratory Syndrome-Coronavirus-2 Spike for the Study of Variants, Vaccines, and Therapeutics Against Coronavirus Disease 2019. Front Microbiol 2022;12:817200. [DOI: 10.3389/fmicb.2021.817200] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Choudhary S, Kanevsky I, Tomlinson L. Animal models for studying covid-19, prevention, and therapy: Pathology and disease phenotypes. Vet Pathol 2022;:3009858221092015. [PMID: 35451341 DOI: 10.1177/03009858221092015] [Reference Citation Analysis]
26 Khan MJR, Raihan R, Islam SMRU, Mannan N, Uddin MJ, Khan NH, Rawnuck T, Bhuiyan AH, Mim F, Reza MS. Renewed Focus on the Threat of Cross-Contamination in Molecular Laboratories: Notes from the COVID-19 Testing Experience in Bangladesh. AID 2021;11:357-65. [DOI: 10.4236/aid.2021.114032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Chen SC, Rawlinson WD. Focus on SARS-CoV-2 and COVID-19. Pathology 2020;52:743-4. [PMID: 33121820 DOI: 10.1016/j.pathol.2020.09.010] [Reference Citation Analysis]